PGR and neoplasm: As shown in Table 1, detailed analyses demonstrated that the expression of NSUN2 is significantly associated with clinical stage (P=0.021), tumor (T) classification (P=0.012), pathological differentiation (P=0.023), ER status (P<0.001), PR status (P=0.001), and Ki-67 expression level (P=0.008).